Navigation Links
Lilly Reports Fourth-Quarter and Full-Year 2008 Results
Date:1/29/2009

ImClone acquisition) $4.35 to $4.55 $4.02 8% to 13% -------------- -------

The company expects volume growth in sales again in 2009, driven by Cymbalta, Alimta, Cialis, Humalog and the anticipated launches of prasugrel, as well as by the Elanco animal health division. However, the negative impact of weaker foreign currencies and the impact of generic competition in certain markets for Gemzar are anticipated to partially offset these positive impacts. As a result, the company expects low-single digit sales growth on a pro-forma non-GAAP basis and mid-single digit sales growth on a reported basis.

The company expects gross margin as a percent of sales to increase, driven by the strengthening dollar. This increase could be more pronounced in the first half of 2009.

Marketing, selling, and administrative expenses are projected to show flat to low-single digit growth. Research and development expenses are projected to grow in the high-single digits on a pro forma non-GAAP basis and in the low-double digits on a reported basis.

Other income is expected to be a net loss of between $200 million and $250 million, and the effective tax rate is expected to be approximately 22 percent. Capital expenditures are expected to be approximately $1.1 billion and the company expects continued strong operating cash flow.

Webcast of Conference Call

As previously announced, investors and the general public can access a live webcast of the fourth-quarter and full-year 2008 financial results conference call through a link on Lilly's website at www.lilly.com. The conference call will be held today from 9:00 a.m. to 10:00 a.m. Eastern Standard Time (EST) and will be available for replay via the website through February 27, 2009.

Lilly, a leadin
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
4. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
5. Lillys CEO Calls for Reform of Nations Drug Safety System
6. Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
7. Lilly Grant to VA Will Enhance Services for Returning Combat Veterans
8. Lilly Delivers Strong Third-Quarter Results
9. Lilly and MacroGenics Announce Licensing and Collaboration Agreement
10. Eli Lilly and Company Aids California Recovery Effort
11. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... Olive Fertility Centre is proud ... Post Graduate Teaching Award on behalf of the department of Family Practice. , “This ... field to be practicing in. The technology is changing so rapidly and we are ...
(Date:7/6/2015)... ... 2015 , ... Longevity, the highest regarded provider of early ... Care to offer on-site health screenings. These ultrasound screenings detect early signs of ... accurate and run about an hour long with same day results. , Early ...
(Date:7/6/2015)... ... July 06, 2015 , ... Health care systems and genomics projects have generated ... to access and use this “Big Data” to improve health and cut costs is ... of the Mount Sinai Health System in New York City. Physicians will have these ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... In a ... learn how to reduce their risk of having a fracture through the bone health ... Fractures Awareness Day. , “We are participating because our residents need this information to ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... World renowned ... the opportunity to achieve their ideal appearance through comprehensive treatment solutions. Individuals that want ... with the doctor and receive a plan that resolves each of their needs. ...
Breaking Medicine News(10 mins):Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:National Bone Health Screening and Awareness Day 2Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2
... "frozen lozenge" provides breakthrough method to help medicine go down , ... "A spoonful of sugar helps the medicine go down" -- parents ... Insight Pharmaceuticals has introduced Sucrets(R) ICE -- unique, frozen single-use packages ... sore throats. , , ...
... most people, family gatherings, parties, and other social activities are part of ... anxiety disorder, who dread--or even avoid--social situations, reports the December 2008 issue ... ... 2, 2008 -- For most people, family gatherings, parties, and other social ...
... News has announced the launch of a new health website providing ... With new advances in medicine, more and more patients are ... surviving cancer. , , ... its risk factors, screening procedures and drugs to treat it, EIN ...
... pancakes, among other products, home to sodium, study says ... plenty of sodium -- commonly known as salt -- in ... that lower-fat foods can have much more sodium than full-fat ... Monday by Consumer Reports magazine. , Researchers analyzed ...
... 2, 2008 Improvements in behavior and screening have contributed ... 1990, with better cancer treatments playing a supporting role, according ... , While not the first to report a long-term ... examine the reasons for this decline. Published in the fall ...
... the Study of Law, Science, and Technology at the ... University will host an international conference on April 3-4, ... science, with special attention to the highly anticipated report ... Needs of the Forensic Sciences Community." , In ...
Cached Medicine News:Health News:New Sucrets(R) ICE Cools Sore Throat Pain 2Health News:Easing Social Anxiety During the Holidays: Tips from Harvard Women's Health Watch 2Health News:EIN News Introduces 'Brain Cancer News Today'; Website Offers Information on Risk Factors, Treatment, Drugs 2Health News:High Salt Levels Common in Many Foods 2Health News:Drop in cancer deaths tied primarily to gains in behavior and screening 2
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/45v9b3/urinary_slings ... Slings Market in the US 2015-2019" report to ... Slings market in the US to grow at a ... This report covers the present scenario and the growth ... for the period 2015-2019. To calculate the market size, ...
(Date:7/6/2015)... , July 6, 2015 Array BioPharma,s ... showcased this past weekend at the 2015 ESMO ... presentation.  At the meeting, data were shared from ... a 100-patient randomized Phase 2 expansion of that ... an EGFR inhibitor, with or without the addition ...
(Date:7/6/2015)... 2015 Akcea Therapeutics, a wholly-owned subsidiary ... announced today that the U.S. Food and Drug ... (ISIS-APOCIII Rx ) for the treatment of patients ... rare genetic disease characterized by extremely high triglyceride ... 2 study published in the NEJM in December ...
Breaking Medicine Technology:United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: